Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T
Conditions
Recurrent Diffuse Large B-Cell Lymphoma · Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified · Recurrent Grade 3b Follicular Lymphoma · Recurrent High Grade B-Cell Lymphoma · Recurrent Primary Mediastinal Large B-Cell Lymphoma · Recurrent Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma · Refractory Diffuse Large B-Cell Lymphoma · Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified · Refractory Grade 3b Follicular Lymphoma · Refractory High Grade B-Cell Lymphoma · Refractory Primary Mediastinal Large B-Cell Lymphoma · Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Contact: Principal Investigator (Mengyang Di, MD, PhD)
Study leads
Mengyang Di, MD, PhD
Principal Investigator
Fred Hutch/University of Washington Cancer Consortium